To elucidate the clinical relevance of FPR2 in the human GC, immunohistochemistry (IHC) was performed to detect the levels of FPR2 expression in tumor tissues and their adjacent normal tissues from 169 GC patients. The gene discussed is FPR2; the disease is gastric cancer.